MedPath

Trials in chronic skin ulcers using new collagen substitutes incorporating basic fibroblast growth factor

Phase 1
Completed
Conditions
Chronic skin ulcers
Registration Number
JPRN-jRCT1092220038
Lead Sponsor
Shigehiko Suzuki
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
17
Inclusion Criteria

1.Patient's ulcer has been present for a minimum of 1 month
2. Maximum area of ulcer is within 70mmx100mm
3.Skin Perfusion Pressure at the proximal margin or distal
margin of patient's ulcer(existing in lower extremity) is more than 30mmHg.
4.age: =>20
5. patients providing written informed consent

Exclusion Criteria

1.Decubitus with pocket
2.Patient's ulcer is with extensive exposure of tendon or bone
3.Ulcer with a infection

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement of wound 2 weeks after implantation
Secondary Outcome Measures
NameTimeMethod
1.adverse event<br>2.wound area<br>3.granulation area
© Copyright 2025. All Rights Reserved by MedPath